Drug-Coated Balloons in Small Vessels: Preferred Strategy to Drug-Eluting Stents?

JACC Cardiovasc Interv. 2023 May 8;16(9):1062-1064. doi: 10.1016/j.jcin.2023.03.005. Epub 2023 Apr 19.

Authors

J Dawn Abbott¹, Joanna J Wykrzykowska², Chris Lenselink²

Affiliations

¹ Lifespan Cardiovascular Institute and Department of Medicine, Division of Cardiology, Alpert Medical School of Brown University, Providence, Rhode Island, USA. Electronic address: jabbott@lifespan.org.
² Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.

PMID: 37164604
DOI: 10.1016/j.jcin.2023.03.005

No abstract available

Keywords: coronary artery disease; drug-coated balloon; drug-eluting balloon; percutaneous coronary intervention; small vessel disease.

Publication types

Editorial
Comment

MeSH terms

Angioplasty, Balloon, Coronary* / adverse effects
Coated Materials, Biocompatible
Coronary Artery Disease* / diagnostic imaging
Coronary Artery Disease* / therapy
Coronary Restenosis* / diagnostic imaging
Coronary Restenosis* / etiology
Coronary Restenosis* / therapy
Drug-Eluting Stents*
Humans
Percutaneous Coronary Intervention* / adverse effects
Stents
Treatment Outcome

Substances

Coated Materials, Biocompatible